Jos Nauta - Concepedia

Author

Jos Nauta

Abbott (Netherlands)

Also Known As

J. P. Jos Nauta, Jos Nauta

Publications

726

Citations

H-Index

Concepts

All Affiliations

Abbott (Netherlands)University of Siena VisMederi Research University of Amsterdam

About

Jos Nauta is an author at Abbott (Netherlands) specializing in medicine, influenza vaccines, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	140
2	Immunology	2	2	121
3	Health Sciences	1	1	60
4	Epidemiology	1	1	19
5	Pharmacology	1	1	60

Jos Nauta

Publications

684

Citations

H-Index

Page 1

	Year	Citations
Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma C. René Leemans, Rammohan Tiwari, Jos Nauta, Cancer	1993	475
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly Iris De Bruijn, Ingo Meyer, Lisya Gerez, Vaccine VaccinationVaccine DevelopmentMedicineVaccine TargetConventional Influenza Vaccines	2007	61
Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia Johanna W. Baars, Jan Paul de Boer, John Wagstaff, British Journal of Haematology Il-2 TherapyImmunologyPharmacotherapyIl-2 InfusionInflammation	1992	60
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study Susanna Esposito, Jos Nauta, Giulia Lapini, Vaccine	2022	24
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China Feng Zhu, Wei-Zhong Zhou, Hongxing Pan, Vaccine VaccinationVaccine SafetyCross-protectionVaccinologyVaccine Efficacy	2008	19
Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized study Timo Vesikari, Jos Nauta, Giulia Lapini, International Journal of Infectious Diseases	2019	17
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses Serge van de Witte, Jos Nauta, Emanuele Montomoli, Vaccine	2018	15
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project Anke L. Stuurman, Miriam Levi, Philippe Beutels, Influenza and Other Respiratory Viruses	2022	13

Page 1